Dr Reddys Laboratories Share Price Today - Live Blog for December 11, 2025

Dr Reddys Laboratories Ltd's stock has surged by 0.16%, and it is currently trading at ₹1,275.65. Additionally, the stock maintains a PE ratio of 18.5500, while the industry PE is 33.3992.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.12% recently. As of now, this stock is actively trading at a current market price of ₹1,274.25 per share, attracting attention from investors.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.18%. At this moment, it's actively trading at ₹1,272.10, presenting an enticing opportunity for those in the market.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.07% gain, with the share price now at ₹1,271.45. Notably, the stock's PE ratio stands at 18.5500, and its Return on Equity (ROE) is 16.0277%.

Dr Reddys Laboratories Ltd observed a -0.11% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,270.00. The stock has a PE ratio of 18.5500, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd stock price decreased by -0.19%, with the current market value at ₹1,272.10 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.08% boost, with the current market value at ₹1,275.00 per share. This surge has not gone unnoticed by investors.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.09% gain, with the share price now at ₹1,274.80. Notably, the stock's PE ratio stands at 18.5500, and its Return on Equity (ROE) is 16.0277%.

Dr Reddys Laboratories Ltd witnessed a notable 0.05% surge in its share price and is presently trading at ₹1,274.65, captivating the attention of market participants.

Dr Reddys Laboratories Ltd observed a remarkable 0.06% surge in its share price and is presently trading at ₹1,274.75. The increased investor interest is driving this surge.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.20% boost, with the current market value at ₹1,273.75 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd's stock has surged by 0.10%, and it is currently trading at ₹1,271.25. Additionally, the stock maintains a PE ratio of 18.5500, while the industry PE is 33.3992.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.02% drop, and it's now trading at ₹1,268.70 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd's stock has surged by 0.16%, and it is currently trading at ₹1,270.00. Additionally, the stock maintains a PE ratio of 18.5500, while the industry PE is 33.3992.

Dr Reddys Laboratories Ltd's stock has surged by 0.15%, and it is currently trading at ₹1,268.20. Additionally, the stock maintains a PE ratio of 18.5500, while the industry PE is 33.3992.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.17% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,266.00 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Demonstrating a commendable 0.23% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,263.00. In terms of valuation, the stock maintains a PE ratio of 18.5500, while the industry PE ratio stands at 33.3992.

After a -0.16% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,260.15. The stock has a PE ratio of 18.5500, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

With a -0.16% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,260.15. Investors should examine the factors driving this decline. The stock's PE ratio is 18.5500, whereas the industry PE ratio stands at 33.3992.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.27% gain, with the share price now at ₹1,263.00. Notably, the stock's PE ratio stands at 18.5500, and its Return on Equity (ROE) is 16.0277%.

After a significant 0.27% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,263.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

With a remarkable 0.06% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,259.60. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.5500, while the industry's PE ratio is 33.3992.

Dr Reddys Laboratories Ltd experienced a substantial 0.13% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,258.85, making it an appealing option for investors.

With a remarkable 0.11% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,252.90. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.5500, while the industry's PE ratio is 33.3992.

Dr Reddys Laboratories Ltd experienced a -0.16% dip in its share price and is currently trading at ₹1,255.30. The stock has a PE ratio of 18.5500, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

With a -0.07% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,257.15. The stock is currently trading at a PE of 18.5500, while the industry PE is 33.3992, prompting investors to assess its value proposition.